The PLXNB subgroup were associated with both survival advantage and disadvantage of a number of cancer types, but PLXNB1 and PLXNB2 were more associated with better survival, while PLXNB3 was more associated with worse survival (Figure 3 and Figure S2). The gene discussed is PLXNB3; the disease is cancer.